Storia in 2 fonti

Aurobindo Pharma arm Eugia Pharma's Telangana unit gets warning letter from USFDA

Aurobindo Pharma's Eugia Pharma unit in Telangana receives a USFDA warning letter after recent inspections, but supply remains unaffected.

Raccontata da

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

Aurobindo Pharma's Eugia Pharma unit in Telangana receives a USFDA warning letter after recent inspections, but supply remains unaffected.

Aurobindo Pharma's subsidiary Eugia Pharma receives a U.S. FDA warning letter following previous compliance issues at its Hyderabad facility.